Health And Medicine

Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI). Read More

The Vanderbilt Comprehensive Care Clinic has received a nearly $40,000 grant for 2013-2014 from the Baptist Healing Trust (BHT) for its Pharmacy Support Program, which provides free or low-cost medications to people with HIV/AIDS. Read More

David Cortez, Ph.D., and his Vanderbilt colleagues report new findings that shed light on fundamental processes involved in DNA replication and have implications for cancer therapies that target these processes. Read More

Knowing who your doctor is — and a couple of facts about that person — may go a long way toward improving patient satisfaction, according to a Vanderbilt study in the Journal of Orthopaedic Trauma. Read More

Ken Lau, Ph.D., a new assistant professor in Cell and Developmental Biology, is out to determine the rules that lead to cells converting from one type to another, for example, when a healthy cell becomes a cancer cell. Read More

Vanderbilt researchers have characterized the chemical structures of a series of DNA-protein “crosslinks” that may lead to better ways to avoid the cancer-causing potential of environmental chemicals and prevent some drug toxicities. Read More

Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB. Read More

Vanderbilt University Medical Center will participate in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital. Read More

A non-invasive measure of electrical brain activity in preterm infants predicts cognitive and communication functioning during early childhood, according to a new Vanderbilt University study. Read More

Vanderbilt researchers have identified a key regulator of cell division. Read More

A multidisciplinary study conducted by the combined efforts of Vanderbilt University graduate students has led to the first evidence that abnormal messenger RNA export from the nucleus to the cytoplasm can cause human disease. Read More

The IDIOM study is designed to compare how a diet with moderate caloric restriction, alone or with long-acting insulin, affects areas of the brain’s dopamine system that are involved in food intake, reward and the sense of pleasure people get from eating. Read More

Inactivation by oxidative stress of specific transcription factors essential for pancreatic islet beta cell function is a key event in the development of type 2 diabetes, Vanderbilt University researchers and their colleagues have found. Read More

Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness. Read More

Vanderbilt University’s Betsy Weiner, Ph.D., R.N., senior associate dean for Informatics in the School of Nursing, and Mark Frisse, M.D., MS, MBA, Accenture Professor and director of Regional Informatics, have been elected to the Institute of Medicine (IOM), the organization announced this week. Read More

Ellen Wright Clayton, M.D., J.D., the Craig-Weaver Professor of Pediatrics and professor of Law at Vanderbilt University, has won the David Rall Medal from the Institute of Medicine (IOM) for “exemplary” service to the institute. Read More

A fungus that is killing frogs and other amphibians around the world releases a toxic factor that disables the amphibian immune response, Vanderbilt University investigators report Oct. 18 in the journal Science. Read More

Vanderbilt University Medical Center has joined a national network funded by the National Institutes of Health to streamline multi-site clinical trials focused on key interventions in stroke prevention, treatment and recovery. Read More

Pediatric Infectious Diseases fellow Annabelle de St. Maurice, M.D., has been awarded a grant to determine the relationship between pneumococcal vaccination and the emergence of certain strains of pneumococcal bacteria not covered by vaccines. Read More

A research team led by Josh Peterson, M.D., MPH, assistant professor of Biomedical Informatics and Medicine, and John Graves, Ph.D., assistant professor of Preventive Medicine, will study the cost-effectiveness of testing patients’ risk of adverse gene-drug interactions. Read More